Label (Abiraterone 250mg 120s Container Label)
Abiraterone Tablet
Product Images NDC 68001-673
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone (NDC 68001-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-01 (Abiraterone Figure 01)
This appears to be a table showing the time to death in months for patients who were administered either Abiraterone or a placebo. The Abiraterone group had higher survival rates compared to the placebo group. However, without more context, it is difficult to determine what the numbers and symbols in the table represent.*
Figure-02 (Abiraterone Figure 02)
This text appears to be a table showing the number of subjects without death over time from randomization in a clinical trial comparing Abiraterone and Placebo. The numbers in the first row represent the months from randomization, and the numbers in the second and third rows are the number of subjects without death in each treatment group for each month. The last row seems to show the difference in the number of subjects without death between the two groups.*
Figure-03 (Abiraterone Figure 03)
The text includes a table showing the number of subjects without Radiographic Progression or Death in a clinical trial of Abiraterone versus placebo. The table shows that there were 698 subjects without progression or death in the Abiraterone group compared to 512 in the placebo group after 12 months of randomization. The table also includes numbers for the different time points from randomization.*
Abiraterone-structure (Abiraterone Structure)
Figure 4
This appears to be a table displaying survival rates for subjects in a study comparing the drugs Abiraterone and Placebo. The numbers 100, 80, 60, 404, and 20 may be related to the study but without context, they are difficult to interpret. The column headings are not available, and the meaning of the "Subjects atrisk" row is unclear.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
